Skip to content


Cancer Nanotechnology

Basic,Translational and Clinical Research

Cancer Nanotechnology Cover Image

Nano Startup Challenge in Cancer – NSC<sup>2<sup>

This special article collection focuses on the Nano Startup Challenge in Cancer – or NSC2 for short – run by the National Cancer Institute (NCI) in partnership with the Centre for Advancing Innovation. Following two award-winning competitions (the Breast Cancer Startup Challenge and the Neuro Startup Challenge) NSC2, the third and biggest in the series of challenges, is structured as an open innovation competition designed to bring promising nanotechnology cancer inventions to market. Cancer Nanotechnology Editors-in-Chief Steven A. Curley and Frederick J. Currell are both serving as judges for the Challenge, and they will be reporting regularly in News & Views pieces with updates, key developments, and on-the-ground insights. The collection will also feature scientific articles from the participants on their inventions.

Edited by: Frederick J. Currell and Steven A. Curley

Deadline for submissions: 18th July 2016

Submission Instructions

Before submitting your manuscript, please ensure you have carefully read the submission guidelines for Cancer Nanotechnology. The complete manuscript should be submitted through the Cancer Nanotechnology submission system. To ensure that you submit to the correct thematic series please select the appropriate thematic series in the drop-down menu upon submission. In addition, indicate within your cover letter that you wish your manuscript to be considered as part of the thematic series 'Nano Startup Challenge in Cancer – NSC2'. All submissions will undergo rigorous peer review and accepted articles will be published within the journal as a collection.

Submissions will also benefit from the usual advantages of open access publication:

  • Rapid publication: Online submission, electronic peer review and production make the process of publishing your article simple and efficient
  • High visibility and international readership in your field: Open access publication ensures high visibility and maximum exposure for your work - anyone with online access can read your article
  • No space constraints: Publishing online means unlimited space for figures, extensive data and video footage
  • Authors retain copyright, licensing the article under a Creative Commons license: articles can be freely redistributed and reused as long as the article is correctly attributed

Sign up to article alerts to keep updated on articles published in Cancer Nanotechnology - including articles published in this thematic series!

2016 Journal Metrics

Latest Tweets